首页> 外国专利> METHOD FOR PREDICTION OF THERAPEUTIC EFFICACY OF SEVERE BRONCHIAL ASTHMA

METHOD FOR PREDICTION OF THERAPEUTIC EFFICACY OF SEVERE BRONCHIAL ASTHMA

机译:预测严重支气管哮喘的治疗效果的方法

摘要

FIELD: medicine.;SUBSTANCE: method involves determining an integral cytokine index as a total arithmetical mean of pro-inflammatory interleukin indices and anti-inflammatory interleukin indices. The cytokine concentration is determined at the moment of aggravation of severe bronchial asthma and after an arrest thereof. The pro-inflammatory cytokines IL-2, IL-4, IL-6, IL-8, TNF-α, INF-γ and the anti-inflammatory cytokines IL-10 are detected for allergic and steroid-dependent severe bronchial asthma. The pro-inflammatory cytokines IL-2, IL-6, IL-8, TNF-α, INF-γ and the anti-inflammatory cytokines IL-4, IL-10 are detected for non-allergic bronchial asthma. If a difference of the integral cytokine index calculated at the moment of aggravation of severe bronchial asthma and the integral cytokine index after the arrest is 1 standard unit or more, a possibility to achieve the high efficacy of the basic anti-inflammatory therapy of severe bronchial asthma is predicted; if the difference is less than 1 standard unit, the basic therapy is predicted to be low-effective.;EFFECT: higher efficacy of basic therapy of severe bronchial asthma.;3 tbl, 2 ex
机译:技术领域:方法:方法涉及确定积分的细胞因子指数作为促炎性白介素指数和抗炎性白介素指数的总算术平均值。在严重的支气管哮喘加重时和其停止后确定细胞因子浓度。对于过敏性和类固醇依赖性严重支气管哮喘,检测到促炎细胞因子IL-2,IL-4,IL-6,IL-8,TNF-α,INF-γ和抗炎细胞因子IL-10。检测非过敏性支气管哮喘的促炎细胞因子IL-2,IL-6,IL-8,TNF-α,INF-γ和抗炎细胞因子IL-4,IL-10。如果重度支气管哮喘加重时计算的积分细胞因子指数与停药后的积分细胞因子指数之差等于或超过1个标准单位,则有可能获得重度支气管炎基本抗炎治疗的高疗效预计会出现哮喘;如果差异小于1个标准单位,则预计基本疗法无效。效果:严重支气管哮喘的基本疗法疗效更高; 3 tbl,2 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号